Sravanthi Cheeti

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Locally Advanced

Positive Breast Cancer

Estrogen Receptor

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical pharmacology and therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

Pharmaceutical research

This page only lists publications with an associated author ORCID identifier.

Publications

Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Mohamed-Eslam F Mohamed, Sandhya Girish, Rita Humeniuk, Silpa Nuthalapati, Amit Desai, Amita Datta-Mannan, Ferdous Gheyas, Jitendra Kanodia, Sravanthi Cheeti, Tong Zhu
Impact of COVID-19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective. Clinical pharmacology and therapeutics (2024)
Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Mohamed-Eslam F Mohamed, Sandhya Girish, Rita Humeniuk, Silpa Nuthalapati, Amit Desai, Amita Datta-Mannan, Ferdous Gheyas, Jitendra Kanodia, Sravanthi Cheeti, Tong Zhu
Impact of COVID-19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective. Clinical pharmacology and therapeutics 116 (1) (2024)
Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology (2024)
Sarat Chandarlapaty, Maura N Dickler, José Alejandro Pérez-Fidalgo, Rafael Villanueva-Vázquez, Jennifer M Giltnane, Mary R Gates, Ching-Wei Chang, Sravanthi Cheeti, Jill Fredrickson, Xiaojing Wang, Ann Collier, Heather M Moore, Ciara Metcalfe, Jennifer Lauchle, Eric W Humke, Aditya Bardia
An open-label phase I study of GDC-0927 in postmenopausal women with locally advanced or metastatic estrogen receptor positive breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sravanthi Cheeti, Hao Helen Hou, Eric Nelson, Helen Walker, Buyun Chen, Roland Morley, Mary Gates, Luna Musib, Sandhya Girish, Srikumar Sahasranaman, Lichuan Liu
Application of a Novel 'Make and Test in Parallel' Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects. Pharmaceutical research 35 (12) (2018)